Home Dementias Revolutionary CRISPR-based genome editing doubles life expectancy in mice with Glioblastoma, improving...

Revolutionary CRISPR-based genome editing doubles life expectancy in mice with Glioblastoma, improving overall survival rate by about 30% : braincancer

This is fantastic news and grounds for a real breakthrough but a couple caveats: the journey from mice to humans is a long one. Further, some of the biggest challenges remain in targeted delivery of therapy. However, it warms my heart to see such progress happening in my lifetime.

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

7 days remaining to share your experiences

submitted by /u/FMazzaschi Continue Reading to the Source

Revolutionary CRISPR-based genome editing doubles life expectancy in mice with Glioblastoma, improving overall survival rate by about 30% : braincancer

This is fantastic news and grounds for a real breakthrough but a couple caveats: the journey from mice to humans is a long one....

Recent Comments